Data / Form D filings / Cellens, Inc.
Cellens, Inc.: Form D filings
Cellens, Inc., a health care company in Boston, MA, filed 2 Form D notices with the SEC between 2022 and 2025. The latest, on November 14, 2025, reports $6.4 million sold of a $6.4 million offering to 33 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 529 Main Street, Suite 1M6, Boston, MA, 02129
- Phone
- (857) 285-3227
- Industry
- Other Health Care
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2020
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1926630
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 14, 2025 | New notice | $6,440,526 | $6,440,526 | 33 | Aug 14, 2025 | sec.gov | |
| Oct 14, 2022 | New notice | $1,500,000 | $585,000 | $915,000 | 15 | Apr 20, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Deborah Zajac | Director | |
| Lena Chaihorsky-Hering | Director | |
| Mohan Iyer | Director | |
| Jesse Salk | Director | |
| Phuong (Jean) Pham | Executive Officer, Director |
Other health care companies in Massachusetts that filed recently
- XRHealth, Inc. $3.9 million · Oct 23, 2026
- Fresenius Medical Care Fulshear, LLC $4.4 million · Oct 21, 2026
- Nocturnal Inc. $1.9 million · Oct 20, 2026
- Mikri Inc. $1.4 million · Oct 19, 2026
- Soterya, Inc. $850,000 · Oct 13, 2026
- ArthroMeda, Inc. $8.7 million · Oct 13, 2026
Every Form D from the week of Nov 10, 2025 · All recent filings in Massachusetts · All recent Other Health Care filings
Read from SEC EDGAR. Amount sold is what Cellens, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.